These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

516 related articles for article (PubMed ID: 5755831)

  • 1. Anti-arrhythmic properties of 1,5-dimorpholino-3-(1-naphthyl)-pentane (DA 1686).
    Bianchi C; Sanna GP; Turba C
    Arzneimittelforschung; 1968 Jul; 18(7):845-50. PubMed ID: 5755831
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antifibrillatory properties of new alkoxynaphthoic acid-esters in comparison with quinidine and procaine amide].
    Igarashi T; Hashimoto N
    Arzneimittelforschung; 1968 Oct; 18(10):1274-8. PubMed ID: 5755706
    [No Abstract]   [Full Text] [Related]  

  • 3. [Antiarrhythmic effect of oxylidine].
    Zaĭtseva KA; Mashkovskiĭ MD
    Farmakol Toksikol; 1970; 33(3):305-9. PubMed ID: 4393832
    [No Abstract]   [Full Text] [Related]  

  • 4. [Metoclopramide and electrocardiographic changes caused by KC1, BaC12, CaC12, MgC12, aconitine, k-strophanthoside, vasopressin and by asphyxia].
    Marmo E; Di Giacomo S; Imperatore A
    Arzneimittelforschung; 1970 Jan; 20(1):12-8. PubMed ID: 4191693
    [No Abstract]   [Full Text] [Related]  

  • 5. [Antiarrhythmic properties of fubromegan on different models of experimental cardiac arrhythmia].
    Samvelian VM; L'vov MV
    Farmakol Toksikol; 1970; 33(3):309-13. PubMed ID: 4393833
    [No Abstract]   [Full Text] [Related]  

  • 6. [Antiarrhythimic properties of ethmozine].
    Kaverina NV; Senova ZP; Vikxliàev IuI; Ul'iànova OV
    Farmakol Toksikol; 1970; 33(6):693-7. PubMed ID: 4103389
    [No Abstract]   [Full Text] [Related]  

  • 7. Acute toxicity and general pharmacologic properties of 1,5-dimorpholino-3-(1-naphthyl)-pentane: DA 1686.
    Turba C; Sanna GP; Bianchi C
    Arzneimittelforschung; 1968 Sep; 18(9):1127-32. PubMed ID: 4387882
    [No Abstract]   [Full Text] [Related]  

  • 8. A comparison of the antiarrhythmic actions of two new synthetic compounds, iproveratril and MJ 1999, with quinidine and pronethalol.
    Schmid JR; Hanna C
    J Pharmacol Exp Ther; 1967 May; 156(2):331-8. PubMed ID: 4381702
    [No Abstract]   [Full Text] [Related]  

  • 9. Anti-arrhythmic action of dilazep. Action on experimental arrhythmias induced by g-strophanthin (ouabain), epinephrine and aconitine.
    Sano N; Kawada M; Fukutomi Y
    Arzneimittelforschung; 1974 Nov; 24(11A Suppl):1893-8. PubMed ID: 4141624
    [No Abstract]   [Full Text] [Related]  

  • 10. [Antiarrhythmic effect of beta-N-hexamethyleneimino-para-butoxypropiophenone (TG-17), novocainamide and quinidine in cardiac arrhythmias evoked by strophanthin K in cats].
    Ammar EM; Kudrin AN
    Farmakol Toksikol; 1969; 32(5):566-70. PubMed ID: 5364670
    [No Abstract]   [Full Text] [Related]  

  • 11. [Anti-arrhythmic property of a derivative of propiophenone].
    Duteil J; Cheymol G; Olive G
    Med Pharmacol Exp Int J Exp Med; 1967; 17(3):231-8. PubMed ID: 5631089
    [No Abstract]   [Full Text] [Related]  

  • 12. Antiarrhythmic actions of coronary vasodilator agents papaverine, dioxyline and verapamil.
    Hanna C; Schmid JR
    Arch Int Pharmacodyn Ther; 1970 Jun; 185(2):228-33. PubMed ID: 5473785
    [No Abstract]   [Full Text] [Related]  

  • 13. Antiarrhythmic action of atropine.
    Viana AP; Osswald W
    Arch Int Pharmacodyn Ther; 1971 Aug; 192(2):238-46. PubMed ID: 4106043
    [No Abstract]   [Full Text] [Related]  

  • 14. [The anti-arrhythmic activity of EDTA tetrabutylamide].
    Gendenshteĭn EI
    Biull Eksp Biol Med; 1966 Jul; 62(7):71-3. PubMed ID: 4988482
    [No Abstract]   [Full Text] [Related]  

  • 15. Antiarrhythmic effects of proadifen hydrochloride (SKF 525-A).
    Viana AP; Osswald W
    Arzneimittelforschung; 1970 Jun; 20(6):851-3. PubMed ID: 5468902
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effects of a new anti-arrhythmic drug, bunaftine, on intra-atrial, atrio-ventricular and intraventricular conduction of the stimulus].
    Grazi S; Romano S; Bonazzi O; Pozzoni L; Cavoretto D; Gardumi M; Sardella F
    Cardiol Prat; 1974; 25(3):213-8. PubMed ID: 4434374
    [No Abstract]   [Full Text] [Related]  

  • 17. Absorption, excretion and metabolism of 1,5-dimorpholino-3-(1-naphthyl)-pentane (DA 1686) in rats and rabbits.
    Coppi G; Bonardi G; Perego R
    Arzneimittelforschung; 1968 Oct; 18(10):1343-5. PubMed ID: 5755717
    [No Abstract]   [Full Text] [Related]  

  • 18. [Comparative evaluation of the antiarrhythmic effect of derivatives of diphenylacetic acid and novocaine amide].
    Serdiuk EN; Koval'chuk LA
    Farmakol Toksikol; 1971; 34(2):168-70. PubMed ID: 5563386
    [No Abstract]   [Full Text] [Related]  

  • 19. [Anti-arrhythmic properties of specific bradycardic agents from the group of 2-mercaptobenzimidazole derivatives].
    Chichkanov GG; Tsorin IB; Kirsanova GIu; Berdiaev SIu; Turilova AI
    Eksp Klin Farmakol; 1997; 60(5):35-9. PubMed ID: 9483403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cardioactive and related properties of N-methyl-N-( -phenylethyl)-1,2,3,4-tetrahydro-6-methoxy-4,4-dimethyl-2-naphthylamine hydrochloride (2-AT-1).
    Graeff DM; Johnson WE; Martin AR
    Arch Int Pharmacodyn Ther; 1971 Sep; 193(1):134-48. PubMed ID: 4398737
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 26.